--- title: "Director Robert C. Malenka Reports Sale of Maplight Therapeutics Inc. Common Shares" description: "Robert C. Malenka, Director of Maplight Therapeutics Inc., has reported the sale of common shares of the company. The full filing is available through the provided link. This news brief was generated " type: "news" locale: "en" url: "https://longbridge.com/en/news/274900553.md" published_at: "2026-02-05T02:15:36.000Z" --- # Director Robert C. Malenka Reports Sale of Maplight Therapeutics Inc. Common Shares > Robert C. Malenka, Director of Maplight Therapeutics Inc., has reported the sale of common shares of the company. The full filing is available through the provided link. This news brief was generated by Public Technologies and is for informational purposes only, not to be considered as financial, investment, or legal advice. Maplight Therapeutics Inc. is responsible for the original content published via EDGAR on February 04, 2026. Robert C. Malenka, Director of Maplight Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Maplight Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002021198-26-000005), on February 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here ### Related Stocks - [MPLT.US - MapLight Therapeutics](https://longbridge.com/en/quote/MPLT.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 董事 Robert C. Malenka 报告了出售 MapLight Therapeutics Inc.普通股 | 罗伯特·C·马伦卡董事报告了对 Maplight Therapeutics Inc.普通股的处置。完整的文件可以通过提供的链接访问。此消息由公共技术公司(PUBT)生成,仅供信息参考,不构成财务或法律建议。原始内容由 Maplight Th | [Link](https://longbridge.com/en/news/274371236.md) | | NVR 公司的一位董事出售了 200 股股票 | NVR 董事 Susan Williamson Ross 于 2026 年 2 月 13 日以每股 7,922.06 美元的价格出售了 200 股 NVR, Inc.普通股,总计 1,584,412 美元。交易后,Ross 直接持有 386 | [Link](https://longbridge.com/en/news/276156708.md) | | 董事 Robert A. Schriesheim 出售 Houlihan Lokey Inc.的普通股 | Houlihan Lokey Inc. 的董事 Robert A. Schriesheim 已出售该公司的普通股。完整的文件可通过提供的链接获取。此消息由 Public Technologies 生成,仅供参考,不应被视为财务、投资或法律建 | [Link](https://longbridge.com/en/news/275469228.md) | | Cibc World Market Inc. 向 QXO, Inc. 投资了 122 万美元 | Cibc World Market Inc. 在其 13F 文件中报告,已通过在第三季度收购 64,153 股投资了 122 万美元于 QXO, Inc. 其他机构投资者,包括先锋集团和 Affinity Partners,也增加了他们在 | [Link](https://longbridge.com/en/news/276106337.md) | | 董事长、首席执行官兼总裁 Robert H. Schottenstein 报告出售 M/I Homes Inc.的普通股 | 罗伯特·H·肖滕斯坦,M/I Homes Inc. 的董事长、首席执行官兼总裁,报告了公司普通股的出售。完整的文件可通过提供的链接获取。此新闻简报由公共技术公司生成,仅供信息参考,不应被视为财务、投资或法律建议。M/I Homes Inc. | [Link](https://longbridge.com/en/news/275658198.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.